tiprankstipranks
4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
US Market
FDMT
4D Molecular Therapeutics
RESEARCH TOOLSreports

4D Molecular Therapeutics (FDMT) Balance Sheet

513 Followers

4D Molecular Therapeutics Balance Sheet

4D Molecular Therapeutics's total assets for Q4 2025 were $566.71M, an increase of 33.66% from the previous quarter. FDMT total liabilities were $61.05M for the fiscal quarter, a 11.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 566.71M$ 560.38M$ 339.89M$ 261.85M$ 353.49M
Total Liabilities
$ 61.05M$ 49.78M$ 32.06M$ 30.51M$ 34.38M
Total Equity Gross Minority
$ 505.66M$ 510.61M$ 307.83M$ 231.34M$ 319.11M
Other Metrics
Currency in USD

4D Molecular Therapeutics Debt to Assets